FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 3864072 · Received June 10, 2014

Report

Report Number
1416980-2014-18570
Event Type
Injury
Date Received
June 10, 2014
Date of Event
June 1, 2014
Report Date
May 19, 2014
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ADDITIONAL INFORMATION: THE PATIENT DEVELOPED PERITONITIS ON AN UNSPECIFIED DATE IN (B)(6) 2014. THIS IS A REPORT OF A PATIENT WHO EXPERIENCED A BREAK IN ASEPTIC TECHNIQUE RESULTING IN PERITONITIS. PER BAXTER LABELING, USERS ARE INSTRUCTED TO USE ASEPTIC TECHNIQUE WHEN PERFORMING PERITONEAL DIALYSIS THERAPY. A FORMAL REVIEW OF THE LABEL FOR THE PRODUCT FAMILY WILL BE CONDUCTED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). THE PATIENT EXPERIENCED PERITONITIS ON (B)(6) 2014 (PREVIOUSLY REPORTED AS AN UNSPECIFIED DATE IN (B)(6) 2014). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT HAD A BREAK IN ASEPTIC TECHNIQUE DURING PERITONEAL DIALYSIS THERAPY WHICH RESULTED IN THE DEVELOPMENT OF PERITONITIS. THE PERITONITIS WAS MANIFESTED BY CLOUDY EFFLUENT. THE PATIENT DID NOT REQUIRE HOSPITALIZATION BUT WAS TREATED WITH UNSPECIFIED ANTIBIOTICS INTRAPERITONEALLY (DOSE, ROUTE, AND FREQUENCY NOT REPORTED) FOR THE EVENT. IT WAS NOT REPORTED IF THE PATIENT WAS RETRAINED ON PROPER ASEPTIC TECHNIQUE. AT THE TIME OF THIS REPORT, THE PATIENT HAD RECOVERED FROM THE PERITONITIS. DIANEAL THERAPY WAS ONGOING. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
338642 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 68 YR Required Intervention DIANEAL 1.5% AND 2.5% LOW CA SINGLEBAG| DIANEAL LOW CALCIUM| DIANEAL 1.5% AND 4.25% LOW CA ULTRABAG